Related Experiment Video

Updated: Jul 13, 2026

A Zebrafish Model of Diabetes Mellitus and Metabolic Memory
10:03

A Zebrafish Model of Diabetes Mellitus and Metabolic Memory

Published on: February 28, 2013

The treat-to-target A1C approach to control type 2 diabetes and prevent complications

Russell D White1

  • 1University of Missouri, Kansas City School of Medicine at Kansas City, Missouri, USA. jockdoc2000@hotmail.com

Advances in Therapy
|July 31, 2007
PubMed

Insights

Initiating insulin therapy earlier in type 2 diabetes management can improve glycemic control and reduce complications. Evidence-based protocols guide effective insulin initiation and titration to achieve target A1C levels.

Area of Science:

  • Endocrinology
  • Metabolic Diseases
  • Pharmacology

Background:

  • Type 2 diabetes management often delays insulin initiation until oral agents fail.
  • Achieving near-normal glycosylated hemoglobin (A1C) reduces microvascular and macrovascular complications.
  • Effective glycemic control is crucial for preventing long-term diabetes-related health issues.

Purpose of the Study:

  • To review evidence on initiating insulin therapy in type 2 diabetes patients inadequately controlled by oral agents.
  • To assess the efficacy and safety of various insulin regimens (basal, premixed, analogs).
  • To present evidence-based protocols for insulin initiation and titration.

Main Methods:

  • Systematic review of randomized clinical trials.
  • Analysis of studies comparing human insulins and insulin analogs.
  • Evaluation of different insulin regimens for achieving target A1C goals.

Main Results:

  • Insulin therapy, when initiated appropriately, can achieve target A1C levels more effectively.
  • Various insulin regimens demonstrate efficacy in controlling hyperglycemia.
  • Evidence supports systematic protocols for insulin initiation and dose adjustment.

Conclusions:

  • Early and optimized insulin therapy is key for managing type 2 diabetes.
  • Evidence-based protocols enhance the initiation and titration of insulin regimens.
  • Achieving target A1C levels with insulin reduces diabetes-related complications.

Related Concept Videos

Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis01:25

Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis

Type 2 diabetes mellitus develops gradually and is often asymptomatic in early stages.Clinical ManifestationsWhen symptoms appear, they include fatigue, blurred vision, pruritus, delayed wound healing, and recurrent infections, particularly candidal infections. Peripheral neuropathy may present as numbness or tingling in the extremities. Classic hyperglycemia symptoms—polyuria, polydipsia, and polyphagia—are less common. Most patients are overweight and frequently have associated hypertension...
Type II Diabetes I: Introduction01:26

Type II Diabetes I: Introduction

Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
Carbohydrate Metabolism01:36

Carbohydrate Metabolism

Carbohydrates are polymers composed of molecules containing atoms of carbon, hydrogen and oxygen. One gram of carbohydrate can provide four kilo-calories of energy, which makes it the most efficient instant energy source.
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in the...